{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:03:01Z","timestamp":1789635781038,"version":"4.0.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005363","name":"University of Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003947","name":"UNLP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.actatropica.2026.108271","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:26:52Z","timestamp":1786145212000},"page":"108271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative study of lipidic and polymeric nanoparticles encapsulating benznidazole in an acute mice model of Chagas disease"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4785-8050","authenticated-orcid":false,"given":"Giuliana","family":"Muraca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-3406","authenticated-orcid":false,"given":"Sebasti\u00e1n","family":"Scioli-Montoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3271-6305","authenticated-orcid":false,"given":"Emilia Mercedes","family":"Barrionuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Marchetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8617-667X","authenticated-orcid":false,"given":"Mar\u00eda Esperanza","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Yamil","family":"Chain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-4592","authenticated-orcid":false,"given":"Vera Alejandra","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7293-7028","authenticated-orcid":false,"given":"Tom\u00e1s Mariano","family":"MacLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3782-0187","authenticated-orcid":false,"given":"Jessica","family":"Minnaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Huck-Iriart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9099-586X","authenticated-orcid":false,"given":"Diego Germ\u00e1n","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n Abel","family":"Islan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-826X","authenticated-orcid":false,"given":"Alan","family":"Talevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2724-0421","authenticated-orcid":false,"given":"Catalina Dirney","family":"Alba Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2026.108271_bib0001","doi-asserted-by":"crossref","first-page":"e2907","DOI":"10.1371\/journal.pntd.0002907","article-title":"Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults","volume":"8","author":"Altcheh","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108271_bib0002","series-title":"Chagas Disease: a Clinical Approach","author":"Altech","year":"2019"},{"key":"10.1016\/j.actatropica.2026.108271_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112678","article-title":"Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy","volume":"217","author":"Arrua","year":"2022","journal-title":"Colloid. Surf. B Biointerface."},{"key":"10.1016\/j.actatropica.2026.108271_bib0004","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41579-019-0238-x","article-title":"Protozoan persister-like cells and drug treatment failure","volume":"17","author":"Barrett","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12978-020-00972-1","article-title":"Short-course benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol","volume":"17","author":"Cafferata","year":"2020","journal-title":"Reprod. Health"},{"key":"10.1016\/j.actatropica.2026.108271_bib0006","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s00436-013-3398-z","article-title":"P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance","volume":"112","author":"Campos","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2026.108271_bib0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actatropica.2026.108271_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01383-20","article-title":"Pharmacokinetics of benznidazole in experimental chronic Chagas disease using the Swiss mouse-Berenice-78 Trypanosoma cruzi strain model","volume":"65","author":"de Jesus","year":"2021","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.actatropica.2026.108271_bib0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425247.4.4.403","article-title":"Drug delivery strategies for poorly water-soluble drugs","volume":"4","author":"Fahr","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actatropica.2026.108271_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.actatropica.2018.02.008","article-title":"Technological innovation strategies for the specific treatment of Chagas disease based on benznidazole","volume":"185","author":"Ferraz","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2026.108271_bib0012","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/pharmaceutics13111912","article-title":"Annatto oil loaded nanostructured lipid carriers: a potential new treatment for cutaneous leishmaniasis","volume":"13","author":"Ferreira","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actatropica.2026.108271_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/expr.1999.4389","article-title":"Giardia lamblia: incorporation of free and conjugated fatty acids into glycerol-based phospholipids","volume":"92","author":"Gibson","year":"1999","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0014","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0168-3659(92)90182-Q","article-title":"The influence of endogenous surfactant on the structure and drug-release properties of Eudragit NE30D-matrices","volume":"18","author":"G\u00f6pferich","year":"1992","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.actatropica.2026.108271_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.colsurfa.2013.12.023","article-title":"Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation","volume":"444","author":"Kova\u010devi\u0107","year":"2014","journal-title":"Colloid. Surf. Physicochem. Eng. Asp."},{"key":"10.1016\/j.actatropica.2026.108271_bib0016","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/bcp.14700","article-title":"Review of pharmacological options for the treatment of Chagas disease","volume":"88","author":"Lascano","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0017","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF03190490","article-title":"The design of pharmacokinetic studies to support drug discovery: the selection of the optimum number of animals for a study","volume":"28","author":"Law","year":"2003","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.actatropica.2026.108271_bib0018","first-page":"920","article-title":"Colloidal stability of polymeric nanoparticles in biological fluids","volume":"14","author":"Lazzari","year":"2012","journal-title":"J. Nanopart. Res. Interdiscip. Forum Nanoscale Sci. Technol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bioorg.2018.03.025","article-title":"Acetylenic fatty acids from Porcelia macrocarpa (Annonaceae) against trypomastigotes of Trypanosoma cruzi: effect of octadec-9-ynoic acid in plasma membrane electric potential","volume":"78","author":"Londero","year":"2018","journal-title":"Bioorgan. Chem."},{"key":"10.1016\/j.actatropica.2026.108271_bib0020","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/s41564-023-01496-7","article-title":"Adipocyte lipolysis protects mice against Trypanosoma brucei infection","volume":"8","author":"Machado","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0021","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1021\/acsinfecdis.0c00353","article-title":"Chagas disease: current view of an ancient and global chemotherapy challenge","volume":"6","author":"Mart\u00edn-Escolano","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108271_bib0022","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10973-011-1371-6","article-title":"Polymorphic screen and drug\u2013excipient compatibility studies of the antichagasic benznidazole","volume":"106","author":"Maximiano","year":"2011","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.actatropica.2026.108271_bib0023","doi-asserted-by":"crossref","first-page":"e1852","DOI":"10.1002\/wnan.1852","article-title":"Recent approaches in nanocarrier-based therapies for neglected tropical diseases","volume":"15","author":"Mengarda","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.actatropica.2015.08.004","article-title":"A flow cytometer-based method to simultaneously assess activity and selectivity of compounds against the intracellular forms of Trypanosoma cruzi","volume":"152","author":"Miranda","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2026.108271_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01912-16","article-title":"Pharmacokinetics of benznidazole in healthy volunteers and implications in future clinical trials","volume":"61","author":"Molina","year":"2017","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.actatropica.2026.108271_bib0026","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1186\/s13063-023-07659-5","article-title":"Correction: efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized phase II non-inferiority clinical trial","volume":"24","author":"Molina-Morant","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.actatropica.2026.108271_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/08982104.2023.2268711","article-title":"Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery","volume":"34","author":"Munir","year":"2024","journal-title":"J. Lipos. Res."},{"key":"10.1016\/j.actatropica.2026.108271_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.601151","article-title":"Trypanosomatid-caused conditions: state of the art of therapeutics and potential applications of lipid-based nanocarriers","volume":"8","author":"Muraca","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.actatropica.2026.108271_bib0029","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3762\/bjnano.14.66","article-title":"Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies","volume":"14","author":"Muraca","year":"2023","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/sci1020048","article-title":"Evaluation of dissolution enhancement of aprepitant drug in ternary pharmaceutical solid dispersions with Soluplus\u00ae and Poloxamer 188 prepared by melt mixing","volume":"1","author":"Nanaki","year":"2019","journal-title":"Sci"},{"key":"10.1016\/j.actatropica.2026.108271_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00347-18","article-title":"Novel approaches to kill toxoplasma gondii by exploiting the uncontrolled uptake of unsaturated fatty acids and vulnerability to lipid storage inhibition of the parasite","volume":"62","author":"Nolan","year":"2018","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.actatropica.2026.108271_bib0032","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/ntrev-2015-0055","article-title":"Making drugs safer: improving drug delivery and reducing the side effect of drugs on the human biochemical system","volume":"5","author":"Odiba","year":"2016","journal-title":"Nanotechnol. Rev."},{"key":"10.1016\/j.actatropica.2026.108271_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185033","article-title":"Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease","volume":"12","author":"Olivera","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.actatropica.2026.108271_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2021.665274","article-title":"Nano based approach for the treatment of neglected tropical diseases","volume":"3","author":"Pandian","year":"2021","journal-title":"Front. Nanotechnol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2020.107834","article-title":"Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas\u2019 disease with absence of parasitism in blood, heart and colon","volume":"210","author":"Perin","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108271_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02410-16","article-title":"Pharmacokinetics and tissue distribution of benznidazole after oral administration in mice","volume":"61","author":"Perin","year":"2017","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.actatropica.2026.108271_bib0037","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/infdis\/154.5.825","article-title":"Human milk kills Giardia lamblia by generating toxic lipolytic products","volume":"154","author":"Reiner","year":"1986","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108271_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123358","article-title":"Efficacy of benznidazole delivery during Chagas disease nanotherapy is dependent on the nanocarrier morphology","volume":"322","author":"Scariot","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.actatropica.2026.108271_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.actatropica.2026.108271_bib0040","first-page":"59","article-title":"Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential","volume":"25","author":"Shah","year":"2014","journal-title":"J. Phys. Sci."},{"key":"10.1016\/j.actatropica.2026.108271_bib0041","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1208\/s12249-010-9495-8","article-title":"A preformulation study of a new medicine for Chagas disease treatment: physicochemical characterization, thermal stability, and compatibility of benznidazole","volume":"11","author":"Soares-Sobrinho","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.actatropica.2026.108271_bib0042","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1208\/s12249-019-1337-8","article-title":"Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability","volume":"20","author":"Talegaonkar","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.actatropica.2026.108271_bib0043","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Method. Mol. Biol. Clifton NJ"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26003049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26003049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:21:07Z","timestamp":1789633267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X26003049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0001706X26003049"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108271","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative study of lipidic and polymeric nanoparticles encapsulating benznidazole in an acute mice model of Chagas disease","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108271"}}